Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-28 @ 2:07 AM
Study NCT ID:
NCT06089369
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2023-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Sponsor:
Tongji Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Adjuvant-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None